General Atlantic-promoted pharma company Rubicon Research is set to launch its Rs 1,377.5-crore initial public offering (IPO) on October 9. This would be the third public issue hitting Dalal Street next week along with Tata Capital's Rs 15,512-crore IPO, and LG Electronics India's Rs 11,607-crore offer.